Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie, G O
Paraneoplastic myasthenia gravis: immunological and clinical aspects. [electronic resource] - European journal of neurology Oct 2008 - 1029-33 p. digital
Publication Type: Comparative Study; Journal Article; Review
1468-1331
10.1111/j.1468-1331.2008.02242.x doi
Age of Onset
Atrophy
Autoantibodies--immunology
Autoantigens--immunology
Combined Modality Therapy
Connectin
Humans
Hyperplasia
Immunosuppressive Agents--therapeutic use
Middle Aged
Muscle Proteins--immunology
Myasthenia Gravis--drug therapy
Nerve Tissue Proteins--immunology
Paraneoplastic Polyneuropathy--drug therapy
Plasmapheresis
Prognosis
Protein Kinases--immunology
Receptors, Cholinergic--immunology
Ryanodine Receptor Calcium Release Channel--immunology
Thymectomy
Thymoma--complications
Thymus Gland--pathology
Thymus Neoplasms--complications
Paraneoplastic myasthenia gravis: immunological and clinical aspects. [electronic resource] - European journal of neurology Oct 2008 - 1029-33 p. digital
Publication Type: Comparative Study; Journal Article; Review
1468-1331
10.1111/j.1468-1331.2008.02242.x doi
Age of Onset
Atrophy
Autoantibodies--immunology
Autoantigens--immunology
Combined Modality Therapy
Connectin
Humans
Hyperplasia
Immunosuppressive Agents--therapeutic use
Middle Aged
Muscle Proteins--immunology
Myasthenia Gravis--drug therapy
Nerve Tissue Proteins--immunology
Paraneoplastic Polyneuropathy--drug therapy
Plasmapheresis
Prognosis
Protein Kinases--immunology
Receptors, Cholinergic--immunology
Ryanodine Receptor Calcium Release Channel--immunology
Thymectomy
Thymoma--complications
Thymus Gland--pathology
Thymus Neoplasms--complications